{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:33:31Z","timestamp":1783492411007,"version":"3.55.0"},"reference-count":132,"publisher":"Elsevier","isbn-type":[{"value":"9780443295188","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["FISR_04819"],"award-info":[{"award-number":["FISR_04819"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA21145"],"award-info":[{"award-number":["CA21145"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.enz.2024.05.013","type":"book-chapter","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T14:12:12Z","timestamp":1717855932000},"page":"213-241","source":"Crossref","is-referenced-by-count":3,"title":["Helicobacter pylori CAs inhibition"],"prefix":"10.1016","author":[{"given":"Bianca Laura","family":"Bernardoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concettina","family":"La Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"D\u2019Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/bs.enz.2024.05.013_bib1","article-title":"Antimicrobial resistance incidence and risk factors among Helicobacter pylori\u2013infected persons, United States","volume":"10","author":"Duck","year":"2004","journal-title":"Emerg. Infect. Dis. J. \u2013 CDC"},{"key":"10.1016\/bs.enz.2024.05.013_bib2","first-page":"1359","article-title":"Worldwide prevalence and risk factors of Helicobacter pylori infection in children","volume":"9","author":"Borka Balas","year":"2022","journal-title":"Children (Basel)"},{"key":"10.1016\/bs.enz.2024.05.013_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.gastro.2017.04.022","article-title":"Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis","volume":"153","author":"Hooi","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.enz.2024.05.013_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/bs.enz.2024.05.013_bib5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/clinchem\/hvad081","article-title":"Updates to the diagnosis and clinical management of Helicobacter pylori infections","volume":"69","author":"Shakir","year":"2023","journal-title":"Clin. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5001\/omj.2019.37","article-title":"WHO global priority pathogens list: a bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in bahrain","volume":"34","author":"Asokan","year":"2019","journal-title":"Oman Med. J."},{"key":"10.1016\/bs.enz.2024.05.013_bib7","unstructured":"European Centre for Disease Prevention, World Health Organization, editors. Antimicrobial Resistance Surveillance in Europe 2023\u20132021 Data. Stockholm, 2023."},{"key":"10.1016\/bs.enz.2024.05.013_bib8","unstructured":"The Helicobacter Found. https:\/\/helico.com\/."},{"key":"10.1016\/bs.enz.2024.05.013_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fgstr.2022.965982","article-title":"European Registry on Helicobacter pylori Management (Hp-EuReg): Most relevant results for clinical practice","volume":"1","author":"Nyssen","year":"2022","journal-title":"Front. Gastroenterol."},{"key":"10.1016\/bs.enz.2024.05.013_bib10","unstructured":"Helicobacter pylori | CDC Yellow Book, 2024. https:\/\/wwwnc.cdc.gov\/travel\/yellowbook\/2024\/infections-diseases\/helicobacter-pylori (accessed April 10, 2024)."},{"key":"10.1016\/bs.enz.2024.05.013_bib11","doi-asserted-by":"crossref","unstructured":"J.B. Nemhauser, CDC Yellow Book. 2024: Health Information for International Travel. OUP USA, 2023.","DOI":"10.1093\/oso\/9780197570944.001.0001"},{"key":"10.1016\/bs.enz.2024.05.013_bib12","article-title":"Global knowledge mapping and emerging trends in Helicobacter pylori-related precancerous lesions of gastric cancer research: a bibliometric analysis from 2013 to 2023","volume":"102","author":"Xiong","year":"2023","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/bs.enz.2024.05.013_bib13","unstructured":"National Cancer Institute. Helicobacter pylori (H. pylori) and Cancer. https:\/\/www.cancer.gov\/about-cancer\/causes-prevention\/risk\/infectious-agents\/h-pylori-fact-sheet (accessed April 11, 2024)."},{"key":"10.1016\/bs.enz.2024.05.013_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/antibiotics12020191","article-title":"Helicobacter pylori infection: current status and future prospects on diagnostic, therapeutic and control challenges","volume":"12","author":"Elbehiry","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/bs.enz.2024.05.013_bib15","first-page":"2417","article-title":"The effect of Helicobacter pylori infection on overweight: a systematic review and meta-analysis","volume":"51","author":"Kamarehei","year":"2022","journal-title":"Iran. J. Public Health"},{"key":"10.1016\/bs.enz.2024.05.013_bib16","article-title":"The association between Helicobacter pylori infection with overweight\/obesity: a protocol for a systematic review and meta-analysis of observational studies","volume":"99","author":"Chen","year":"2020","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/bs.enz.2024.05.013_bib17","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.3748\/wjg.v24.i32.3617","article-title":"Helicobacter pylori infection and liver diseases: epidemiology and insights into pathogenesis","volume":"24","author":"Okushin","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/bs.enz.2024.05.013_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00203-023-03602-z","article-title":"The possible role of Helicobacter pylori in liver diseases","volume":"205","author":"Mohammadi","year":"2023","journal-title":"Arch. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12879-022-07718-3","article-title":"Relationship between active Helicobacter pylori infection and risk factors of cardiovascular diseases, a cross-sectional hospital-based study in a Sub-Saharan setting","volume":"22","author":"Tali","year":"2022","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/bs.enz.2024.05.013_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.imr.2016.05.005","article-title":"Helicobacter pylori and cardiovascular complications: a mechanism based review on role of Helicobacter pylori in cardiovascular diseases","volume":"5","author":"Jamkhande","year":"2016","journal-title":"Integr. Med. Res."},{"key":"10.1016\/bs.enz.2024.05.013_bib21","article-title":"Helicobacter pylori and autoimmune diseases: involving multiple systems","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/bs.enz.2024.05.013_bib22","first-page":"13","article-title":"Role of Helicobacter pylori infection in Hispanic patients with anemia","volume":"106","author":"Ortiz","year":"2014","journal-title":"Bol. Asoc. Med. P. R."},{"key":"10.1016\/bs.enz.2024.05.013_bib23","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/alz.13561","article-title":"Clinically apparent Helicobacter pylori infection and the risk of incident Alzheimer\u2019s disease: a population-based nested case-control study","volume":"20","author":"Douros","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/bs.enz.2024.05.013_bib24","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s10620-008-0557-7","article-title":"Helicobacter pylori infection as a risk factor for insulin resistance","volume":"54","author":"Eshraghian","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/bs.enz.2024.05.013_bib25","first-page":"S1016","article-title":"Association of Helicobacter pylori infection with metabolic and hormonal disorders: 2448","volume":"110","author":"Aldossari","year":"2015","journal-title":"Off. J. Am. Coll. Gastroenterology|ACG|Gastroenterology|ACG"},{"key":"10.1016\/bs.enz.2024.05.013_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12929-018-0469-6","article-title":"H. pylori infection and extra-gastroduodenal diseases","volume":"25","author":"Tsay","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/bs.enz.2024.05.013_bib27","doi-asserted-by":"crossref","unstructured":"I. D\u2019Agostino, S. Carradori. Urease. In Metalloenzymes From Bench to Bedside, chapter 5.1, pp. 393-410, 1st Edition - Elsevier, London, UK, September 15, 2023, Editors: Claudiu T. Supuran, William Alexander Donald, ISBN: 9780128239742. https:\/\/doi.org\/10.1016\/B978-0-12-823974-2.00035-8.","DOI":"10.1016\/B978-0-12-823974-2.00035-8"},{"key":"10.1016\/bs.enz.2024.05.013_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/microorganisms12010222","article-title":"Helicobacter pylori: a contemporary perspective on pathogenesis, diagnosis and treatment strategies","volume":"12","author":"Ali","year":"2024","journal-title":"Microorganisms"},{"key":"10.1016\/bs.enz.2024.05.013_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/914791","article-title":"Biofilm formation by Helicobacter pylori and its involvement for antibiotic resistance","volume":"2015","author":"Yonezawa","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/bs.enz.2024.05.013_bib30","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.3390\/ijms22094823","article-title":"Helicobacter pylori outer membrane vesicles and extracellular vesicles from Helicobacter pylori-infected cells in gastric disease development","volume":"22","author":"Gonz\u00e1lez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2024.05.013_bib31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.micro.091208.073413","article-title":"Biological functions and biogenesis of secreted bacterial outer membrane vesicles","volume":"64","author":"Kulp","year":"2010","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2672.2012.05351.x","article-title":"Helicobacter pylori biofilm: a protective environment for bacterial recombination","volume":"113","author":"Grande","year":"2012","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib33","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3389\/fmicb.2015.01369","article-title":"Helicobacter pylori ATCC 43629\/NCTC 11639 outer membrane vesicles (OMVs) from biofilm and planktonic phase associated with extracellular DNA (eDNA)","volume":"6","author":"Grande","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/bs.enz.2024.05.013_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3390\/antibiotics12020332","article-title":"Evolution of Helicobacter pylori resistance to antibiotics: a topic of increasing concern","volume":"12","author":"Boyanova","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/bs.enz.2024.05.013_bib36","first-page":"646","article-title":"Effectiveness of Helicobacter pylori treatments according to antibiotic resistance","volume":"119","author":"Bujanda","year":"2024","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/bs.enz.2024.05.013_bib37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance\u2014from biology to clinical implications","volume":"18","author":"Tshibangu-Kabamba","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/bs.enz.2024.05.013_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/antibiotics12060946","article-title":"Newer, older, and alternative agents for the eradication of Helicobacter pylori infection: a narrative review","volume":"12","author":"Buz\u00e1s","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/bs.enz.2024.05.013_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2180-11-96","article-title":"Stimulation of growth of the human gastric pathogen Helicobacter pylori by atmospheric level of oxygen under high carbon dioxide tension","volume":"11","author":"Park","year":"2011","journal-title":"BMC Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib40","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1128\/JB.188.5.1750-1761.2006","article-title":"Involvement of the HP0165-HP0166 two-component system in expression of some acidic-pH-upregulated genes of Helicobacter pylori","volume":"188","author":"Wen","year":"2006","journal-title":"J. Bacteriol."},{"key":"10.1016\/bs.enz.2024.05.013_bib41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/JB.00848-09","article-title":"Cytoplasmic histidine kinase (HP0244)-regulated assembly of urease with urei, a channel for urea and its metabolites, CO2, NH3, and NH4+, is necessary for acid survival of Helicobacter pylori","volume":"192","author":"Scott","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/bs.enz.2024.05.013_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1523-5378.2005.00306.x","article-title":"Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study","volume":"10","author":"Shahidzadeh","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/bs.enz.2024.05.013_bib43","first-page":"93","article-title":"Carbonic anhydrase inhibitors in the treatment of gastro-duodenal ulcer","volume":"30","author":"Puscas","year":"1975","journal-title":"G. E. N."},{"key":"10.1016\/bs.enz.2024.05.013_bib44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0016-5085(64)80129-3","article-title":"A note on the oral dose of acetazolamide required to inhibit acid secretion in man","volume":"46","author":"Lindner","year":"1964","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.enz.2024.05.013_bib45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1476-5381.1956.tb01064.x","article-title":"The effect of acetazoleamide, an inhibitor of carbonic anhydrase, on gastric secretion","volume":"11","author":"Poller","year":"1956","journal-title":"Br. J. Pharmacol. Chemother."},{"key":"10.1016\/bs.enz.2024.05.013_bib46","first-page":"120","article-title":"The effect of acetazolamide on gastric secretion in normal subjects and in patients of chronic gastritis confirmed by biopsy","volume":"2","author":"Cheli","year":"1956","journal-title":"Minerva Gastroenterol."},{"key":"10.1016\/bs.enz.2024.05.013_bib47","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JB.01492-06","article-title":"The HP0165-HP0166 two-component system (ArsRS) regulates acid-induced expression of HP1186 alpha-carbonic anhydrase in Helicobacter pylori by activating the pH-dependent promoter","volume":"189","author":"Wen","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/bs.enz.2024.05.013_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/14756366.2015.1051042","article-title":"The history and rationale of using carbonic anhydrase inhibitors in the treatment of peptic ulcers. In memoriam Ioan Pu\u015fca\u015f (1932\u20132015)","volume":"31","author":"Buz\u00e1s","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib49","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0016-5085(98)70633-X","article-title":"The role of internal urease in acid resistance of Helicobacter pylori","volume":"114","author":"Scott","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.enz.2024.05.013_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00232-006-0867-7","article-title":"Urea transport in bacteria: acid acclimation by gastric Helicobacter spp","volume":"212","author":"Sachs","year":"2006","journal-title":"J. Membr. Biol."},{"key":"10.1016\/bs.enz.2024.05.013_bib51","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1128\/JB.01263-12","article-title":"Role of the Helicobacter pylori sensor kinase ArsS in protein trafficking and acid acclimation","volume":"194","author":"Marcus","year":"2012","journal-title":"J. Bacteriol."},{"key":"10.1016\/bs.enz.2024.05.013_bib52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.tim.2017.05.002","article-title":"Helicobacter pylori, its urease and carbonic anhydrases, and macrophage nitric oxide synthase","volume":"25","author":"Tsikas","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib53","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.femsim.2004.10.021","article-title":"Mutational analysis of the Helicobacter pylori carbonic anhydrases","volume":"44","author":"Nils St\u00e4hler","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib54","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/JB.187.2.729-738.2005","article-title":"The periplasmic alpha-carbonic anhydrase activity of Helicobacter pylori is essential for acid acclimation","volume":"187","author":"Marcus","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/bs.enz.2024.05.013_bib55","doi-asserted-by":"crossref","first-page":"831","DOI":"10.2174\/092986712799034824","article-title":"Inhibition of bacterial carbonic anhydrases and zinc proteases: from orphan targets to innovative new antibiotic drugs","volume":"19","author":"Supuran","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.629163","article-title":"Carbonic anhydrases: new perspectives on protein functional role and inhibition in Helicobacter pylori","volume":"12","author":"Campestre","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib57","first-page":"1","article-title":"An overview of novel antimicrobial carbonic anhydrase inhibitors","author":"Supuran","year":"2023","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/bs.enz.2024.05.013_bib58","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2174\/0929867321666141012174921","article-title":"An overview of the selectivity and efficiency of the bacterial carbonic anhydrase inhibitors","volume":"22","author":"Capasso","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib59","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/14756366.2022.2055009","article-title":"Biological investigation of N-methyl thiosemicarbazones as antimicrobial agents and bacterial carbonic anhydrases inhibitors","volume":"37","author":"D\u2019Agostino","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib60","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2201402","article-title":"Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships","volume":"38","author":"Fantacuzzi","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib61","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/138161208783877875","article-title":"The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets","volume":"14","author":"Nishimori","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.enz.2024.05.013_bib62","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","article-title":"Structure\u2013activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae","volume":"7","author":"Hewitt","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/bs.enz.2024.05.013_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14756366.2021.1991336","article-title":"Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae","volume":"37","author":"Abutaleb","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib64","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1080\/14756366.2019.1663416","article-title":"Anti-Helicobacter pylori activity of ethoxzolamide","volume":"34","author":"Modak","year":"2019","journal-title":"J. Enzyme Inhibition Medicinal Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib65","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13099-020-00358-5","article-title":"Antibacterial activity of ethoxzolamide against Helicobacter pylori strains SS1 and 26695","volume":"12","author":"Rahman","year":"2020","journal-title":"Gut Pathog."},{"key":"10.1016\/bs.enz.2024.05.013_bib66","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1021\/jm0512600","article-title":"Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs","volume":"49","author":"Nishimori","year":"2006","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/bs.enz.2024.05.013_bib67","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.bmcl.2006.01.044","article-title":"Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated \u03b1-carbonic anhydrase from Helicobacter pylori","volume":"16","author":"Nishimori","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2024.05.013_bib68","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.bmcl.2007.04.063","article-title":"Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors","volume":"17","author":"Nishimori","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2024.05.013_bib69","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1107\/S2053230X15010407","article-title":"Structure of \u03b1-carbonic anhydrase from the human pathogen Helicobacter pylori","volume":"71","author":"Compostella","year":"2015","journal-title":"Acta Crystallogr. F. Struct. Biol. Commun."},{"key":"10.1016\/bs.enz.2024.05.013_bib70","unstructured":"RCSB Protein Data Bank. RCSB PDB - 4XFW. https:\/\/www.rcsb.org\/structure\/4XFW."},{"issue":"6","key":"10.1016\/bs.enz.2024.05.013_bib71","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/bioinformatics\/btt607","article-title":"Protter: interactive protein feature visualization and integration with experimental proteomic data","volume":"30","author":"Omasits","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/bs.enz.2024.05.013_bib72","series-title":"Targeting Carbonic Anhydrases","first-page":"2","article-title":"Targeting carbonic anhydrases","author":"Capasso","year":"2014"},{"key":"10.1016\/bs.enz.2024.05.013_bib73","unstructured":"AlphaFold Protein Structure Database. AlphaFold\u2014O24855. https:\/\/alphafold.ebi.ac.uk\/entry\/O24855."},{"key":"10.1016\/bs.enz.2024.05.013_bib74","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib75","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-4838(00)00204-1","article-title":"Cloning, expression and some properties of alpha-carbonic anhydrase from Helicobacter pylori","volume":"1544","author":"Chirica","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/bs.enz.2024.05.013_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127149","article-title":"Structural basis for the inhibition of Helicobacter pylori \u03b1-carbonic anhydrase by sulfonamides","volume":"10","author":"Modakh","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2024.05.013_bib77","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1021\/pr800957q","article-title":"QuatIdent: a web server for identifying protein quaternary structural attribute by fusing functional domain and sequential evolution information","volume":"8","author":"Shen","year":"2009","journal-title":"J. Proteome Res."},{"key":"10.1016\/bs.enz.2024.05.013_bib78","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/bioinformatics\/16.4.404","article-title":"The PSIPRED protein structure prediction server","volume":"16","author":"McGuffin","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/bs.enz.2024.05.013_bib79","first-page":"1","article-title":"Carbonic anhydrase and bacterial metabolism: a chance for antibacterial drug discovery","author":"Capasso","year":"2024","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/bs.enz.2024.05.013_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2022.102203","article-title":"Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics","volume":"70","author":"Vita","year":"2022","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/bs.enz.2024.05.013_bib81","article-title":"Identification of antimotilins, novel inhibitors of Helicobacter pylori flagellar motility that inhibit stomach colonization in a mouse model","volume":"13","author":"Suerbaum","year":"2022","journal-title":"mBio"},{"key":"10.1016\/bs.enz.2024.05.013_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fphar.2011.00034","article-title":"Bacterial carbonic anhydrases as drug targets: toward novel antibiotics?","volume":"2","author":"Supuran","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/bs.enz.2024.05.013_bib83","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/IAI.00993-07","article-title":"Roles of alpha and beta carbonic anhydrases of Helicobacter pylori in the urease-dependent response to acidity and in colonization of the murine gastric mucosa","volume":"76","author":"Bury-Mon\u00e9","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/bs.enz.2024.05.013_bib84","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.enz.2024.05.013_bib85","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert. Opin. Drug. Discov."},{"key":"10.1016\/bs.enz.2024.05.013_bib87","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543776.2020.1811853","article-title":"Antibacterial carbonic anhydrase inhibitors: an update on the recent literature","volume":"30","author":"Supuran","year":"2020","journal-title":"Expert. Opin. Ther. Pat."},{"key":"10.1016\/bs.enz.2024.05.013_bib88","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1749-6632.1984.tb12392.x","article-title":"Treatment of gastroduodenal ulcers with carbonic anhydrase inhibitors","volume":"429","author":"Pu\u015fca\u015f","year":"1984","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.enz.2024.05.013_bib89","first-page":"97","article-title":"Treatment of duodenal ulcers with ethoxzolamide, an inhibitor of gastric mucosa carbonic anhydrase","volume":"24","author":"Puscas","year":"1986","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/bs.enz.2024.05.013_bib90","first-page":"1","article-title":"Novel carbonic anhydrase inhibitors for the treatment of Helicobacter pylori infection","author":"Supuran","year":"2024","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/bs.enz.2024.05.013_bib91","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1107\/S0907444902003451","article-title":"The protein data bank","volume":"58","author":"Berman","year":"2002","journal-title":"Acta Crystallogr. D. Biol. Crystallogr."},{"key":"10.1016\/bs.enz.2024.05.013_bib92","doi-asserted-by":"crossref","first-page":"11098","DOI":"10.1021\/acs.jmedchem.6b01333","article-title":"Structure-activity relationship for sulfonamide inhibition of Helicobacter pylori \u03b1-carbonic anhydrase","volume":"59","author":"Modak","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib93","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/acsmedchemlett.8b00334","article-title":"Famotidine, an antiulcer agent, strongly inhibits Helicobacter pylori and human carbonic anhydrases","volume":"9","author":"Angeli","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2024.05.013_bib94","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ejmech.2018.08.096","article-title":"Discovery of new 2, 5-disubstituted 1,3-selenazoles as selective human carbonic anhydrase IX inhibitors with potent anti-tumor activity","volume":"157","author":"Angeli","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/14756366.2018.1547287","article-title":"Inhibition of bacterial \u03b1-, \u03b2- and \u03b3-class carbonic anhydrases with selenazoles incorporating benzenesulfonamide moieties","volume":"34","author":"Angeli","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib96","doi-asserted-by":"crossref","DOI":"10.4155\/fmc-2023-0208","article-title":"Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition","author":"Benito","year":"2023","journal-title":"Future Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib97","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib98","doi-asserted-by":"crossref","unstructured":"PLOS ONE Staff . Correction: structural basis for the inhibition of Helicobacter pylori \u03b1-carbonic anhydrase by sulfonamides. PLoS One 10 (2015) e0132763. https:\/\/doi.org\/10.1371\/journal.pone.0132763.","DOI":"10.1371\/journal.pone.0132763"},{"key":"10.1016\/bs.enz.2024.05.013_bib99","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00535-008-2240-3","article-title":"Cloning, polymorphism, and inhibition of beta-carbonic anhydrase of Helicobacter pylori","volume":"43","author":"Morishita","year":"2008","journal-title":"J. Gastroenterol."},{"key":"10.1016\/bs.enz.2024.05.013_bib100","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/1871520623666230220162506","article-title":"Coumarin-pyrazoline hybrids as selective inhibitors of the tumor-associated carbonic anhydrase IX and XII","volume":"23","author":"Redij","year":"2023","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib101","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1080\/14756366.2021.1945049","article-title":"Multitargeting approaches involving carbonic anhydrase inhibitors: hybrid drugs against a variety of disorders","volume":"36","author":"Supuran","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib102","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/antiox10010056","article-title":"Dual carbonic anhydrase IX\/XII inhibitors and carbon monoxide releasing molecules modulate LPS-mediated inflammation in mouse macrophages","volume":"10","author":"Berrino","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/bs.enz.2024.05.013_bib103","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00003495-198632030-00001","article-title":"Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome","volume":"32","author":"Campoli-Richards","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/bs.enz.2024.05.013_bib104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0149-2918(96)80177-9","article-title":"The tolerability and safety profile of famotidine","volume":"18","author":"Howden","year":"1996","journal-title":"Clin. Ther."},{"key":"10.1016\/bs.enz.2024.05.013_bib105","first-page":"179","article-title":"Novel compounds, 1,3-selenazine derivatives, as antibacterial agents against Escherichia coli and Staphylococcus aureus","volume":"101","author":"Koketsu","year":"1998","journal-title":"Res. Commun. Mol. Pathol. Pharmacol."},{"key":"10.1016\/bs.enz.2024.05.013_bib106","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/14756366.2016.1186020","article-title":"Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2H-thiopyran-4-yl based thiazoles and selenazoles","volume":"31","author":"\u0141\u0105czkowski","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40360-016-0046-0","article-title":"In vitro antibacterial activities of p-toluenesulfonyl-hydrazinothiazoles and hydrazinoselenazoles against multi-drug resistant Gram-negative phenotypes","volume":"17","author":"Mbaveng","year":"2016","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/bs.enz.2024.05.013_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300267","article-title":"Antimalarial agents targeting plasmodium falciparum carbonic anhydrase: towards dual acting artesunate hybrid compounds","author":"D\u2019Agostino","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/bs.enz.2024.05.013_bib109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/tcrm.2006.2.4.435","article-title":"Role of erlotinib in the management of pancreatic cancer","volume":"2","author":"Starling","year":"2006","journal-title":"Ther. Clin. Risk Manag."},{"issue":"Suppl 1","key":"10.1016\/bs.enz.2024.05.013_bib110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/1163018-S0-000000000-00000","article-title":"Role of erlotinib in the treatment of non-small cell lung cancer: clinical outcomes in wild-type epidermal growth factor receptor patients","volume":"72","author":"Piperdi","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/bs.enz.2024.05.013_bib111","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3389\/fonc.2019.01308","article-title":"Epidermal growth factor receptor family and its role in gastric cancer","volume":"9","author":"Arienti","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.enz.2024.05.013_bib112","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5009\/gnl.2013.7.5.552","article-title":"The effect of Helicobacter pylori on epidermal growth factor receptor-induced signal transduction and the preventive effect of celecoxib in gastric cancer cells","volume":"7","author":"Kim","year":"2013","journal-title":"Gut Liver"},{"key":"10.1016\/bs.enz.2024.05.013_bib113","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/toxins11100591","article-title":"Tyrosine kinases in Helicobacter pylori infections and gastric cancer","volume":"11","author":"Chichirau","year":"2019","journal-title":"Toxins (Basel)"},{"key":"10.1016\/bs.enz.2024.05.013_bib114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol. Oncol."},{"key":"10.1016\/bs.enz.2024.05.013_bib115","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2166503","article-title":"Click chemistry approaches for developing carbonic anhydrase inhibitors and their applications","volume":"38","author":"Angeli","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib116","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10096-011-1220-3","article-title":"Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains","volume":"30","author":"Dol\u00e9ans-Jordheim","year":"2011","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/bs.enz.2024.05.013_bib117","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.micpath.2018.01.037","article-title":"Pathogenic features of Streptococcus mutans isolated from dental prosthesis patients and diagnosed cancer patients with dental prosthesis","volume":"116","author":"Alanazi","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/bs.enz.2024.05.013_bib118","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1771","article-title":"Bacterial infections in cancer: a bilateral relationship","volume":"14","author":"Basu","year":"2022","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol"},{"key":"10.1016\/bs.enz.2024.05.013_bib119","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/ijmr.IJMR_339_19","article-title":"Effects of infections on the pathogenesis of cancer","volume":"153","author":"Emanuele Liardo","year":"2021","journal-title":"Indian. J. Med. Res."},{"key":"10.1016\/bs.enz.2024.05.013_bib120","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1016\/j.bmc.2009.05.002","article-title":"Carbonic anhydrase inhibitors. Inhibition and homology modeling studies of the fungal beta-carbonic anhydrase from Candida albicans with sulfonamides","volume":"17","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib121","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3109\/14756366.2011.649268","article-title":"Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions","volume":"28","author":"Maresca","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2024.05.013_bib122","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bmcl.2009.11.124","article-title":"Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II\u2013trithiocarbonate adduct\u2014an inhibitor mimicking the sulfonamide and urea binding to the enzyme","volume":"20","author":"Temperini","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/bs.enz.2024.05.013_bib123","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.bmcl.2009.02.088","article-title":"Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2024.05.013_bib124","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/md20110721","article-title":"Carbonic anhydrase inhibitors from marine natural products","volume":"20","author":"Supuran","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/bs.enz.2024.05.013_bib125","doi-asserted-by":"crossref","first-page":"11583","DOI":"10.3390\/ijms222111583","article-title":"Selective inhibition of Helicobacter pylori carbonic anhydrases by carvacrol and thymol could impair biofilm production and the release of outer membrane vesicles","volume":"22","author":"Grande","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2024.05.013_bib126","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.3390\/ijms24054455","article-title":"Antimicrobial and antibiofilm activities of carvacrol, amoxicillin and salicylhydroxamic acid alone and in combination vs. Helicobacter pylori: towards a new multi-targeted therapy","volume":"24","author":"Puca","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2024.05.013_bib127","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1080\/10408398.2019.1675585","article-title":"The antibacterial properties of phenolic isomers, carvacrol and thymol","volume":"60","author":"Kachur","year":"2020","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/bs.enz.2024.05.013_bib128","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11101-018-9569-x","article-title":"Carvacrol and its derivatives as antibacterial agents","volume":"17","author":"Marinelli","year":"2018","journal-title":"Phytochem. Rev."},{"key":"10.1016\/bs.enz.2024.05.013_bib129","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.3390\/molecules25184125","article-title":"Thymol and thyme essential oil-new insights into selected therapeutic applications","volume":"25","author":"Kowalczyk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/bs.enz.2024.05.013_bib130","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/antibiotics12050824","article-title":"Carvacrol\u2014a natural phenolic compound with antimicrobial properties","volume":"12","author":"M\u0105czka","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/bs.enz.2024.05.013_bib131","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/ph13110405","article-title":"Synthesis and biological evaluation of carvacrol-based derivatives as dual inhibitors of H. pylori strains and AGS cell proliferation","volume":"13","author":"Sisto","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/bs.enz.2024.05.013_bib132","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/molecules26071829","article-title":"Synthesis and evaluation of thymol-based synthetic derivatives as dual-action inhibitors against different strains of H. pylori and AGS cell line","volume":"26","author":"Sisto","year":"2021","journal-title":"Molecules"}],"container-title":["The Enzymes","Bacterial Carbonic Anhydrases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604724000131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604724000131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T11:21:15Z","timestamp":1725103275000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604724000131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443295188"],"references-count":132,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2024.05.013","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}